Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America

PG Pappas, CA Kauffman, DR Andes… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Liposomes for intravitreal drug delivery: a state of the art

A Bochot, E Fattal - Journal of Controlled Release, 2012 - Elsevier
Intravitreal administration of drugs has raised a large interest during the last two decades
improving the treatment of infectious diseases of the posterior segment of the eye or …

Intravitreal injection of therapeutic agents

GA Peyman, EM Lad, DM Moshfeghi - Retina, 2009 - journals.lww.com
Background: Intravitreal injection (IVI) with administration of various pharmacological agents
is a mainstay of treatment in ophthalmology for endopthalmitis, viral retinitis, age-related …

Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases

R Bisht, A Mandal, JK Jaiswal… - Wiley Interdisciplinary …, 2018 - Wiley Online Library
Effective drug delivery to the retina still remains a challenge due to ocular elimination
mechanisms and complex barriers that selectively limit the entry of drugs into the eye. To …

Nanotherapy for posterior eye diseases

IP Kaur, S Kakkar - Journal of Controlled Release, 2014 - Elsevier
It is assumed that more than 50% of the most enfeebling ocular diseases have their origin in
the posterior segment. Furthermore, most of these diseases lead to partial or complete …

Endophthalmitis: a review of current evaluation and management

CA Lemley, DP Han - Retina, 2007 - journals.lww.com
Purpose: To review the current state of evaluation and management of various forms of
endophthalmitis. Methods: A review of the literature is included, encompassing …

Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents

J Riddell IV, GM Comer… - Clinical infectious …, 2011 - academic.oup.com
Endogenous fungal endophthalmitis, involving only the chorioretinal structures or extending
to involve the vitreous (vitritis), is a sight-threatening infection requiring early appropriate …

Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives

T Das, J Joseph, MP Simunovic, A Grzybowski… - Progress in retinal and …, 2023 - Elsevier
Infectious endophthalmitis is a severe intraocular infection caused by bacteria, or less
commonly by fungi. It can occur after penetrating eye procedures, trauma, or the spread of …

Liposomes and nanotechnology in drug development: focus on ocular targets

M Honda, T Asai, N Oku, Y Araki… - International journal …, 2013 - Taylor & Francis
Poor drug delivery to lesions in patients' eyes is a major obstacle to the treatment of ocular
diseases. The accessibility of these areas to drugs is highly restricted by the presence of …

Challenges in the polyene-and azole-based pharmacotherapy of ocular fungal infections

P Lakhani, A Patil, S Majumdar - Journal of Ocular Pharmacology …, 2019 - liebertpub.com
Polyenes and azoles constitute 2 major drug classes in the antifungal armamentarium used
to treat fungal infections of the eye such as fungal keratitis, endophthalmitis, conjunctivitis …